RxDoctor Payments Data

Susan Dasta, DO

Family Medicine · Glendale, CANPI 1851452635

Payments from drug & device makers

$3,210in general payments, 2019–2025

Across 139 payments — averaging $23.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vanda Pharmaceuticals Inc.$805
  • Novo Nordisk$387
  • Lilly USA, LLC$251
  • GSK$233
  • Sanofi Pasteur Inc.$203
  • Merck$199
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$3,210100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,210 in reported general payments places this provider in the 85th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$25,420
Medicare patients
75
Services billed
225

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate31$23,092
Levothyroxine Sodium81$1,177
Atorvastatin Calcium165$832
Pantoprazole Sodium52$621
Rosuvastatin Calcium47$510
Losartan Potassium83$483
Lisinopril66$446
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide31$441
Amlodipine Besylate158$427
Pyridostigmine Bromide12$427
Meloxicam98$401
Escitalopram Oxalate44$352
Benazepril Hcl21$281
Simvastatin47$278
Fluticasone Propionate21$264

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$199$23,09231 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,533 family medicine providers in California.

Other family medicine in Glendale

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →